Is a complete NSE/ASTRAZEN research report available?

No complete published report is available for nse/ASTRAZEN (NSE/ASTRAZEN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

nse/ASTRAZEN stock profile: metrics, valuation and analysis

Market cap	169.6B
Revenue (ttm)	24.3B
Net income (ttm)	1.7B
EPS (ttm)	₹67.8
P/E (trailing)	100.0x
Dividend	₹36.0 (0.52%)
Volume	3,315
Beta	0.25

All NSE/ASTRAZEN indicators

Market & fundamental data

Available fields

211

Groups with data

Currency

INR

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	600
Employees Change	-160%
Employees Change Percent	-21.05
Enterprise value	INR 166.3B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	39.33
Industry PE Fwd	33.69
Isin	INE203A01020
Last refreshed	2026-09-12
Market cap	INR 169.6B
Price	INR 6,755
Price currency	INR
Rev Per Employee	32,000,789.47x
Sector	Healthcare
Sector PE	47.81
Sector PE Fwd	38.12
Sic	2834
Symbol	nse/ASTRAZEN
Website	https://www.astrazeneca.in

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1%
EV Earnings	98.02x
EV/EBIT	78.09x
EV/EBITDA	70.26x
EV/Sales	6.84x
FCF yield	-0.1%
P/B ratio	19.44x
P/E ratio	100.01x
P/S ratio	6.97x
PE Ratio10 Y	120.21x
PE Ratio3 Y	133.95x
PE Ratio5 Y	117.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.75%
EBITDA Margin	9.28%
Gross margin	36.83%
Gross Profit	INR 9B
Gross Profit Growth	9.05%
Gross Profit Growth Q	2.03%
Gross Profit Growth3 Y	10%
Gross Profit Growth5 Y	12.35%
Net Income	INR 1.7B
Net Income Growth	-7.49%
Net Income Growth Q	-32.06%
Net Income Growth Qo Q	-15.49%
Net Income Growth Years	1%
Net Income Growth3 Y	8.45%
Net Income Growth5 Y	14.84%
Pretax Margin	9.39%
Profit Margin	6.97%
Profit Per Employee	INR 2.2M
Profitable Quarters	INR 8
Profitable Years	11
Roa5y	8.9
Roe5y	18.81
ROIC	29.53
Roic5y	75.66

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	21.29%
Cagr15y	11.85%
Cagr1y	-24.59%
Cagr3y	16.16%
Cagr5y	17.15%
Div CAGR10	43.1%
Div CAGR3	31.04%
Div CAGR5	78.26%
EPS Growth	-7.47
EPS Growth Q	-32.06
EPS Growth Qo Q	-15.49
EPS Growth Years	1
EPS Growth3 Y	8.45
EPS Growth5 Y	14.84
Revenue Growth	31.1x
Revenue Growth Q	29.73x
Revenue Growth Qo Q	18.01x
Revenue Growth Quarters	19x
Revenue Growth Years	4x
Revenue Growth3 Y	31.64x
Revenue Growth5 Y	25.05x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 4.5B
Debt	INR 1.1B
Debt EBITDA	INR 0.47
Debt Equity	INR 0.13
Debt FCF	INR -6.63
Equity	INR 8.7B
Interest Coverage	37.22
Net Cash	INR 3.4B
Net Cash By Market Cap	INR 1.99
Net Cash Growth	-32.64%
Net Debt EBITDA	INR -1.49
Net Debt Equity	INR -0.39
Tangible Book Value	INR 8.7B
Tangible Book Value Per Share	INR 349
WACC	5.59

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.02%
Dividend Growth	12.5%
Dividend Growth Years	4%
Dividend per share	INR 36
Dividend Years	8
Dividend Yield	0.52%
Ex Div Date	2026-07-31
Last Dividend	INR 36
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	588.65%
1Y total return	-24.58%
200-day SMA	8,364
3Y total return	56.73%
50-day SMA	7,700.3
50-day SMA vs 200-day SMA	50under200
5Y total return	120.64%
All Time High	10,691
All Time High Change	-36.82%
All Time High Date	2025-06-13
All Time Low	375.7
All Time Low Change	1,698.22%
All Time Low Date	2009-01-27
ATR	152.9
Beta	0.25
Ch YTD	-25.19
High	6,880
High52	9,849.5
High52 Date	2025-11-03
High52ch	-31.42%
Low	6,750
Low52	6,750
Low52 Date	2026-09-11
Low52ch	0%
Ma50ch	-12.28%
Price vs 200-day SMA	-19.24%
RSI	20.17
RSI Monthly	43.57
RSI Weekly	23.51
Sharpe ratio	-1.42x
Sharpe Ratio3y	0.52x
Sharpe Ratio5y	0.5x
Sortino ratio	-1.62
Sortino Ratio3y	1.1
Sortino Ratio5y	1.08
Total Return	0.55%
Tr YTD	-24.85
Tr15y	436.15%
Tr1m	-16.5%
Tr1w	-2.72%
Tr3m	-18.14%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,608,677%
Net Borrowing	-74,800,000
Shares Insiders	6.18%
Shares Institutions	8.22%
Shares Qo Q	0%
Shares Yo Y	-0.02%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	INR -177.9M
Adjusted OCF	-162,300,000
Average Volume	11,973.8x
Bv Per Share	349.1
CAPEX	INR -15.6M
Ch10y	575
Ch15y	424.5
Ch1m	-16.5
Ch1w	-2.72
Ch1y	-24.91
Ch3m	-18.5
Ch3y	54.98
Ch5y	116.7
Ch6m	-23.37
Change	-1.54%
Change From Open	-1.82
Close	6,860.5
Days Gap	0.28
Depreciation Amortization	127,425,000
Dollar Volume	22,392,825
Earnings Date	2026-11-06
EBIT	INR 2.1B
EBITDA	INR 2.3B
EPS	INR 67.85
F Score	1
FCF	INR -167M
FCF EV Yield	-0.1x
Financing CF	-919,700,000
Fiscal Year End	March
Founded	1,979
Graham Number	726.77128
Graham Upside	-89.24
Income Tax	INR 586.3M
Investing CF	186,900,000
Is Primary Listing	0
Last Earnings Date	2026-08-10
Last Report Date	2026-06-30
Lynch Fair Value	INR 1,003
Lynch Upside	-85.16
Ma150	8,228.8
Ma150ch	-17.91%
Ma20	7,116.6
Ma20ch	-5.08%
Net CF	-884,200,000
Next Earnings Date	2026-11-06
Open	6,880
Payment Date	2026-09-08
Position In Range	3.85
Price Date	2026-09-11
Price EBITDA	INR 75.17
Ptbv Ratio	19.44
Relative Volume	0.27x
Revenue	24,320,600,000x
SBC By Revenue	0.05x
Share Based Comp	10,900,000
Tax By Revenue	2.41x
Tax Rate	25.69%
Tr6m	-23.03%
Volume	3,315

NSE/ASTRAZEN (NSE/ASTRAZEN)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/ASTRAZEN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/ASTRAZEN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NSE/ASTRAZEN

Frequently asked questions